WALTHAM, Mass.--(BUSINESS WIRE)--InnoCentive, Inc., the pioneer in open innovation and crowdsourcing, and the Sandler-Kenner Foundation for Pancreatic Cancer today announced the launch of a Challenge seeking new approaches for diagnosing pancreatic cancer in its early stages, when the likelihood of patient survival is highest.
